To
assess the risks of non-sterility each organization should develop a
contamination control strategy. This requires an assessment, acknowledgement
and remediation process for contamination risks. A contamination control
strategy will be multifaceted and complex; as a means of addressing some of the
basics and in raising some points for consideration, this article discusses the
key starting points to be included in contamination control strategy for
aseptically produced products.
In
relation to this, Tim Sandle has written an article for American Pharmaceutical
Review. The reference is:
To view the article, click here.
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology